MedTrace Logo

Vectron T500 (Broflanilide 50WP) for IRS in Tanzania Tanzania

NCT05150808 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 12500

Last updated 2021-12-09

No results posted yet for this study

Summary

Malaria is a major public health problem in Africa. An important way to control the disease is by Indoor Residual Spraying of insecticide in houses. Insecticide resistance has become a major problem. This trial will evaluate a novel insecticide against those insecticide resistant mosquito vectors in Tanzania E Africa.

Conditions

  • Malaria,Falciparum

Interventions

OTHER

IRS insecticide: Vectron T500

public health insecticide

Sponsors & Collaborators

  • National Institute for Medical Research, Tanzania

    collaborator OTHER_GOV

  • Kilimanjaro Christian Medical Centre, Tanzania

    collaborator OTHER

  • London School of Hygiene and Tropical Medicine

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
6 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2022-06-30
Completion
2022-12-31

Countries

  • Tanzania
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05150808 on ClinicalTrials.gov